Clinical research in developing countries
Recent Moral Arguments
Bibliographic Data
| ID | 5169712 |
|---|---|
| Authors | Douglas P Lackey (City University of New York, corresponding author) |
| Year | 2002 |
| Volume | 18 |
| Issue | 5 |
| Pages | 1455-1461 |
| Publication date | 2002-10-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Cadernos de Saude Publica (JOURNAL) |
| Journal identifiers | ISSN: 0102-311X • E-ISSN: 1678-4464 |
| Publisher | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/s0102-311x2002000500038 |
| PMID | 12244378 |
| OpenAlex | W2171510296 |
| SciELO | S0102-311X2002000500038 |
| Language | EN |
| Citations received | 3 |
| References cited | 7 |
During the 1990s, bioethicists raised questions about certain clinical trials conducted in developing countries. These inquiries led to revisions in the Declaration of Helsinki and recommendations from the US National Bioethics Advisory Commission. This article raises doubts about the original questions and subsequent recommendations. It is possible that impractical solutions have been proposed for nonexistent ethical problems
Alternative medicine · Bioethics · Clinical trial · Commission · Declaration · Declaration of Helsinki · Developing country · Economic growth · Economics · Engineering ethics · Helsinki declaration · Informed consent · Political science · Biomedical Ethics and Regulation · Engineering · Ethics in Clinical Research · Ethics in medical practice · Law · Medicine
| Citations per year | 0.14 |
|---|---|
| Citation span | 2005 - 2013 (9) |
| Highly cited | No |